Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
Follow MDLN
Alert me
Medline Inc. (MDLN) Operating margin
Medline Inc.'s operating margin over the twelve months to 30 September 2026 was 29.7%, up 21.9 percentage points from fiscal 2025 (7.78%). That is above the Medical Instruments & Supplies industry median of 1.97% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 7.78% | (0.63) |
| FY2024 | 8.41% | 3.03 |
| FY2023 | 5.38% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 6.36% | 1.22 |
| Jun 2026 | 5.14% | (0.60) |
| Mar 2026 | 5.74% | (94.26) |
| Dec 2025 | 100.0% | 90.68 |
| 2 more quarters | Free account |
Operating margin against peers
| Company | Operating margin |
|---|---|
| RMD ResMed Inc. compare | 33.0% |
| MDLN Medline Inc. | 29.7% |
| ISRG Intuitive Surgical, Inc. compare | 28.4% |
| WST West Pharmaceutical Services, Inc. compare | 23.0% |
| COO The Cooper Companies, Inc. compare | 12.8% |
| BDX Becton, Dickinson and Company compare | 11.1% |
| ALC Alcon compare | 8.73% |
| SOLV Solventum Corporation compare | 0.00% |
| BAX Baxter International Inc. compare | −1.90% |
| Medical Instruments & Supplies industry median | 1.97% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on MDLN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Book value per share
- The full statement